Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,252,481 papers from all fields of science
Search
Sign In
Create Free Account
PIK3CB gene
Known as:
PIK3CB
, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
, PI3K-BETA
Expand
This gene is involved in apoptosis, cell growth and angiogenesis.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (1)
PIK3CB wt Allele
Phosphoinositide-3-Kinase, Catalytic, Beta Polypeptide
Phosphorylation
Signal Transduction
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression
Jianbo Tian
,
Ying Zhu
,
+11 authors
X. Miao
Gut
2020
Corpus ID: 216047759
Objective Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. Thus far, most drugs have failed…
Expand
2019
2019
PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer
Bo-Kyung Kim
,
J. Cheong
,
+8 authors
M. Won
Cancers
2019
Corpus ID: 208815945
Although gastric cancer is a common cause of cancer mortality worldwide, its biological heterogeneity limits the available…
Expand
Highly Cited
2018
Highly Cited
2018
PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways
Yulei Zhao
,
Tess Montminy
,
+6 authors
Xiaolong Yang
Molecular Cancer Research
2018
Corpus ID: 4958954
Breast cancer is a leading cause of death in women worldwide. Active mutations of PI3K catalytic subunit PIK3CA (e.g., H1047R…
Expand
2018
2018
PIK3CB/p110&bgr; is a selective survival factor for glioblastoma
Kevin J. Pridham
,
Lamvy Le
,
+8 authors
Z. Sheng
Neuro-Oncology
2018
Corpus ID: 4459183
Background Glioblastoma (GBM) is difficult to treat. Phosphoinositide 3-kinase (PI3K) is an attractive therapeutic target for GBM…
Expand
2017
2017
Functional characterization of a novel somatic oncogenic mutation of PIK3CB
A. Whale
,
Lucy M. Colman
,
Letitia Lensun
,
Helen L. Rogers
,
S. Shuttleworth
Signal Transduction and Targeted Therapy
2017
Corpus ID: 116465
Class I phosphoinositide 3-kinase (PI3K) enzymes have attracted considerable attention as drug targets in cancer therapy over the…
Expand
Highly Cited
2012
Highly Cited
2012
SnapShot: Mammalian Rab Proteins in Endocytic Trafficking
Thierry Galvez
,
J. Gilleron
,
M. Zerial
,
G. O'Sullivan
Cell
2012
Corpus ID: 14452323
Highly Cited
2009
Highly Cited
2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.
R. Crowder
,
C. Phommaly
,
+14 authors
M. Ellis
Cancer Research
2009
Corpus ID: 207686534
Several phosphoinositide 3-kinase (PI3K) catalytic subunit inhibitors are currently in clinical trial. We therefore sought to…
Expand
2007
2007
Targeted RNA interference of phosphatidylinositol 3‐kinase p110‐β induces apoptosis and proliferation arrest in endometrial carcinoma cells
HJ An
,
NH Cho
,
+6 authors
JJ Koh
Journal of Pathology
2007
Corpus ID: 36766800
Phosphatidylinositol 3‐kinase (PI3K) signalling plays a pivotal role in intracellular signal transduction pathways involved in…
Expand
Highly Cited
2006
Highly Cited
2006
Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus
W. Phillips
,
S. Russell
,
+6 authors
I. Campbell
International Journal of Cancer
2006
Corpus ID: 37784592
Mutation of PIK3CA, the gene coding for the p110α catalytic subunit of phosphoinositide 3‐kinase (PI3K), has been reported in a…
Expand
Highly Cited
2004
Highly Cited
2004
Association analysis between longevity in the Japanese population and polymorphic variants of genes involved in insulin and insulin-like growth factor 1 signaling pathways
T. Kojima
,
H. Kamei
,
+9 authors
N. Hirose
Experimental Gerontology
2004
Corpus ID: 13034598
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE